Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDexcom Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 15 | $0.42 | $0.53 | $0.47 |
| Q2 2026 | 15 | $0.58 | $0.65 | $0.60 |
| Q3 2026 | 14 | $0.62 | $0.72 | $0.67 |
| Q4 2026 | 10 | $0.72 | $0.76 | $0.74 |
| Q1 2027 | 10 | $0.60 | $0.63 | $0.62 |
| Q2 2027 | 6 | $0.70 | $0.74 | $0.72 |
| Q3 2027 | 7 | $0.77 | $0.81 | $0.79 |
| Q4 2027 | 6 | $0.85 | $0.89 | $0.87 |
| Q1 2028 | 7 | $0.67 | $0.70 | $0.68 |
| Q2 2028 | 7 | $0.81 | $0.85 | $0.83 |
| Q3 2028 | 12 | $0.88 | $0.93 | $0.91 |
| Q4 2028 | 7 | $1.01 | $1.06 | $1.04 |
Dexcom Inc Earnings Date And Information
Dexcom Inc last posted its earnings results on Thursday, April 30th, 2026. The company reported $0.56 earnings per share for the quarter, topping analysts' consensus estimates of $0.47 by $0.09. The company had revenue of 1.19 B for the quarter and had revenue of 4.66 B for the year. Dexcom Inc has generated $2 earnings per share over the last year ($2.09 diluted earnings per share) and currently has a price-to-earnings ratio of 24.24. Dexcom Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Dexcom Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/30/2026 | Q1 2026 | $0.47 | $0.52 | 0.05 | $1.17 B | $1.19 B |
| 02/12/2026 | Q4 2025 | $0.65 | $0.69 | 0.04 | $1.25 B | $1.26 B |
| 10/30/2025 | Q3 2025 | $0.58 | $0.73 | 0.15 | $1.18 B | $1.21 B |
| 07/30/2025 | Q2 2025 | $0.44 | $0.46 | 0.02 | $1.12 B | $1.16 B |
| 05/01/2025 | Q1 2025 | $0.33 | $0.27 | -0.06 | $1.02 B | $1.04 B |
| 12/31/2024 | Q4 2024 | N/A | $0.39 | N/A | $1.11 B | $1.11 B |
| 10/24/2024 | Q3 2024 | $0.44 | $0.35 | -0.09 | $990.44 M | $994.20 M |
| 07/25/2024 | Q2 2024 | $0.39 | $0.36 | -0.03 | $1.04 B | $1.00 B |
| 04/25/2024 | Q1 2024 | $0.27 | $0.38 | 0.11 | $909.93 M | $921.00 M |
| 02/08/2024 | Q4 2023 | $0.43 | $0.67 | 0.24 | N/A | $1.03 B |
| 10/26/2023 | Q3 2023 | $0.34 | $0.31 | -0.03 | N/A | $975.00 M |
| 07/27/2023 | Q2 2023 | $0.23 | $0.30 | 0.07 | N/A | $871.30 M |
| 04/27/2023 | Q1 2023 | $0.15 | $0.13 | -0.02 | N/A | $741.50 M |
| 02/09/2023 | Q4 2022 | $0.26 | $0.24 | -0.02 | N/A | $815.20 M |
| 10/27/2022 | Q3 2022 | $0.24 | $0.24 | 0 | N/A | $769.60 M |
| 07/28/2022 | Q2 2022 | $0.17 | $0.13 | -0.04 | N/A | $696.20 M |
| 04/28/2022 | Q1 2022 | $0.13 | $0.23 | 0.1 | N/A | $628.80 M |
| 02/14/2022 | Q4 2021 | N/A | -$0.05 | N/A | N/A | $698.20 M |
| 10/28/2021 | Q3 2021 | $0.16 | $0.23 | 0.07 | N/A | $650.20 M |
| 07/29/2021 | Q2 2021 | $0.11 | $0.20 | 0.09 | N/A | $595.10 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Dexcom Inc Earnings: FAQ's
In the previous quarter, Dexcom Inc (:DXCM) reported $0.56 earnings per share (EPS) to beat the analysts' consensus estimate of $0.47 by $0.09.
The conference call for Dexcom Inc's latest earnings report can be listened to online.
The conference call transcript for Dexcom Inc's latest earnings report can be read online.
Dexcom Inc (:DXCM) has a recorded annual revenue of $4.66 B.
Dexcom Inc (:DXCM) has a recorded net income of $836.30 M.Dexcom Inc has generated $2.14 earnings per share over the last four quarters.
Dexcom Inc (:DXCM) has a price-to-earnings ratio of 24.24 and price/earnings-to-growth ratio is 0.32.